Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)
Technology Appraisal Guidance No. 280 Source: National Institute for Health and...
MIMS Publications
MIMS, or the Monthly Index of Medical Specialities, has been providing healthcare professionals with information on prescription medicines every month since its launch in 1959.
MIMS publications are independently compiled by our editorial team and are widely used by healthcare professionals in particular general practitioners, pharmacists and nurse prescribers.
See below for details of our latest MIMS publications including how to obtain your copies.
MIMS Dermatology
- Number 1, 2013
- Clinical Review: Naevoid basal cell carcinoma syndrome
- Identifying infected eczema in children
- Scalp and hair damage from haircare practices
MIMS for Nurses
- Independent Prescriber Formulary December 2009
- Over 1200 updates
- Seven new drug reviews
- Visual guides for respiratory and diabetes devices
MIMS Consultation Guide
- This comprehensive consultation guide is an easily accessible medical resource
- The guide follows the consultation journey in three easy-to-browse chapters
- A must have for GPs, GPs in training, foundation stage doctors, nurses, pharmacists and medical students.
Latest Guidelines
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis (TA282)
Technology Appraisal Guidance No. 282 Source: National Institute for Health and...
Omalizumab for Treating Severe Persistent Allergic Asthma (TA278)
Technology Appraisal Guidance No. 278 Source: National Institute for Health and...
Colistimethate Sodium and Tobramycin Dry Powders for Inhalation for Treating Pseudomonas Lung Infection in Cystic Fibrosis (TA276)
Technology Appraisal Guidance No. 276 Source: National Institute for Health and...
Ranibizumab for the Treatment of Diabetic Macular Oedema (TA274 [Rapid Review of TA237])
Technology Appraisal Guidance No. 274 Source: National Institute for Health and...
2-Part CME Diabetes Program
This activity will explore the latest data on the SGLT-2 inhibitors and implications for practice. Click here.
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
